N. Wazir and S. U. Rehman, “Efficacy and Safety of Empagliflozin as Add-On Therapy in Patients of Type-2 Diabetes Mellitus”, J Gandhara Med Dent Sci, vol. 9, no. 1, pp. 24–27, Jan. 2022.